Breaking NewsTaylor Mammon CBD Bought By US Leader Following Three-Year...

Taylor Mammon CBD Bought By US Leader Following Three-Year Courtship

-

LEADING UK CBD firm Taylor Mammon has been bought by premier US operator GenCanna to create one of the world’s major sector players.

Formed in 2018 Taylor Mammon’s co-founder and Managing Director Nathan Wogman says the deal positions it for ‘significant international growth’.

The move culminates ta three-year partnership during which GenCanna has served as Taylor Mammon’s primary source of CBD and other cannabinoids for infusion into brand products.

Taylor Mammon is a white label manufacturer and brand distributor of CBD-infused goods. GenCanna, is a leading producer of hemp-derived, THC-free, premium CBD and other cannabinoids. 

GenCanna CEO Andrew Barnett said: “As one of our long-term and valued customers, we admired Taylor Mammon’s philosophy and approach to CBD.

“This alliance — which we understand is the first of its kind for a UK-based CBD company — drives unique and mutually beneficial operational and marketing synergies that will catapult product development, sales, and revenue opportunities within our respective geographies.” 

The acquisition follows 18-months work by Taylor Mammon to prepare its Novel Foods Application in tandem with GenCanna. 

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Beauty And Wellness Incubator South West Brands Celebrates Two Major Retail Listings In ASOS And Superdrug For Its Recently Launched Brands, Love, MeMeMe And...

SOUTH West Brands was originated by CEO Rebekah Hall in 2021 with a focus on creating purpose led brand...

European CBD Applications Will Require ‘Complicated And Huge’ Human Studies, Admit EFSA

FOLLOWING the European Food Safety Authority’s (EFSA) controversial decision to ‘stop the clock’ on all CBD novel food applications...

Overseed Becomes First Company To Cultivate Medical Cannabis In France

As reported by NewsWeed SIX months after obtaining ANSM (French Agency for the Safety of Health products) approval and raising...

European Cannabis Stocks Review: Jazz Pharmaceuticals Fails Phase 3 Trail For Sativex, CiiTech Pushes Ahead With IPO Plans

Jazz Pharmaceuticals Jazz Pharmaceuticals, which has become the world’s largest exporter of medical cannabis products since it bought GW...

Food Standards Agency Publishes Updated Public List of CBD Products   

THE FSA is today (30 June 2022) updating its public list of CBD products that can be marketed in...

Cannabis Europa London 2022 Day 2 – Recognise The ‘Size And Immediacy Of The Opportunity To Help Millions Of Patients Across The Continent’

FOLLOWING a packed first day of sessions covering an eclectic and diverse range of topics, the second day narrowed...

Must read

European CBD Applications Will Require ‘Complicated And Huge’ Human Studies, Admit EFSA

FOLLOWING the European Food Safety Authority’s (EFSA) controversial decision...

Overseed Becomes First Company To Cultivate Medical Cannabis In France

As reported by NewsWeed SIX months after obtaining ANSM (French...

You might also likeRELATED
Recommended to you